FindTrial
Sign In

Effects of a Transitional Care Program Based on the Omaha System on Nutritional Status and Quality of Life in Patients with End-Stage Renal Disease: A Randomized Controlled Trial

The impact of continuous care based on the Omaha System on the quality of life of patients in the chronic renal failure - uremia stage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125318
Enrollment
Unknown
Registered
2026-05-25
Start date
2023-10-02
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure,end-stage renal disease

Interventions

Intervention group:Routine nursing care + Continuity of care based on Omaha system (including Omaha system assessment and intervention on post-discharge day 1, 1 month, 3 months, and 6 months, involvi
Control group:Routine nursing care + Routine follow-up and data collection

Sponsors

Urumqi Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with chronic kidney disease (CKD) in accordance with the Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines for diagnosis and staging, defined as kidney damage or an estimated glomerular filtration rate (eGFR) =6 months; 3. Aged >=18 years; 4. Provided informed consent and voluntarily agreed to participate in this study; 5. Free of communication barriers, with the ability to cooperate with the researchers via written or oral communication.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of mental illness; 2. Patients with functional impairment of important organs (excluding those with drug allergies, liver, heart or brain diseases, and kidney transplant patients); 3. Those with concurrent malignant tumors; 4. Those with a survival period of less than one year; 5. Currently participating in similar research; 6. Patients with incomplete clinical data, who withdrew halfway or died.

Design outcomes

Primary

MeasureTime frame
Kidney Disease Quality of Life Short Form Total Score and Domain Scores (KDQOL-SFTM1.3);—

Secondary

MeasureTime frame
Anxiety Level (Generalized Anxiety Disorder-7 Scale);Depression Level (Patient Health Questionnaire-9);Blood Pressure (Systolic/Diastolic);Serum Albumin (ALB);Hemoglobin (Hb);Parathyroid Hormone (PTH);Serum Calcium (Ca);Serum Phosphorus (P);Omaha System Cognitive/Behavioral/Status Scores;Satisfaction Survey;—

Countries

China

Contacts

Public ContactLi Xia

Department of Nursing, Urumqi Friendship Hospital

1181321179@qq.com+86 186 9918 0802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026